Current Issue
Featured Articles in the Current Issue
-
Avoiding Incisional Glaucoma Surgery
Selective laser trabeculoplasty and some MIGS could reduce the need for incisional surgery.
-
An Update on Current Bleb Management
Optimize outcomes by refining trabeculectomy technique.
-
Paradigm Shift in the Medical Management of Glaucoma
New medications and formulations are changing glaucoma treatment.
-
Pathology of the Outflow System
Better understanding is key to targeted glaucoma treatment.
-
The Continuing Evolution of Xen
Thinking outside the eye.
-
WEB EXCLUSIVE: Sustained-Release Technologies for Glaucoma: The Unmet Need
Part 1 of a 4-part physician roundtable on developing advances.
-
WEB EXCLUSIVE: Sustained-Release Technologies for Glaucoma: Devices on the Near Horizon
Part 2 of a 4-part physician roundtable on developing advances.
-
WEB EXCLUSIVE: Sustained-Release Technologies for Glaucoma: Devices on the Far Horizon
Part 3 of a 4-part physician roundtable on developing advances.
-
WEB EXCLUSIVE: Sustained-Release Technologies for Glaucoma: Adoption
Part 4 of a 4-part physician roundtable on developing advances.
Departments and Columns
Glaucoma News Briefs
- FDA Will Review Sustained-Release Bimatoprost Implant
- Ocular Therapeutix 90-Day Insert Barely Misses Endpoint
- Hydrus Registry Results Presented
- iStent Effective at 3 Years in “Real-World” Study
- Aerpio Studying AKB-9778 for Glaucoma
- Zeiss Enters MIGS Space With Acquisition
- Regenerating Retinal Ganglion Cells
- iSTAR MIGS Procedure Effective at 18 Months
- Microstent Trimmers Launched to Trim Stent Protrusions
- Nicox Glaucoma Medication Begins Phase 2 Trial
- Program Offers Easy Access to Xelpros
- Medical Marijuana Sellers Still Recommend It for Glaucoma
- Catalyst for a Cure Begins New Research Phase
- Glaukos Licenses Novel Drug-Delivery Platform
- PolyActiva Studies Sustained-Release Glaucoma Implant
- Tears Could Provide Clues to Glaucoma Diagnosis
- Glaukos Achieves Strong Sales Growth